Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple

Thread starter International: Top News And Analysis
Start date Mar 29, 2026

International: Top News And Analysis

Guest

Mar 29, 2026

This biopharma play with two key drugs for treatment-resistant depression could see its stock rise by more than 230%, according to a Deutsche Bank analyst.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple

Prefix: N/A

Forum: World News

Start date: Mar 29, 2026

Last reply date: Mar 29, 2026

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Mar 29, 2026

Replies: 0

Views: 12

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search